- Comparison of Gefitinib versus Docetaxel in Patients with Pre-Treated Non-Small Cell Lung Cancer (NSCLC)
-
Hirsh V
- KMID: 2199965
- J Lung Cancer.
- 2009 Dec;8(2):61-66.
- doi: 10.6058/jlc.2009.8.2.61
More effective treatments in first, second, and third-line of metastatic non-small cell lung cancer (NSCLC) enable patients to live longer, with a better quality of life (QOL). Especially epidermal growth... -
- CITED
-
- Close
- SHARE
-
- Close
